Larry W McLaughlin

Title: Larry W McLaughlin: Innovator in Nucleic Acid Detection and Anti-Viral Compounds

Introduction

Larry W McLaughlin is a notable inventor based in Dover, MA (US), recognized for his contributions to the fields of nucleic acid detection and anti-viral therapies. With a total of 2 patents, McLaughlin has made significant strides in developing innovative solutions that address critical health challenges.

Latest Patents

Among his latest patents, McLaughlin has developed "Turn over probes and use thereof for nucleic acid detection." This invention provides turnover probes that can be utilized in various detection assays, particularly in nucleic acid detection assays. Additionally, he has patented "Selective anti-viral nucleoside chain terminators," which relates to dideoxynucleoside analog compounds that exhibit selective anti-viral activity with low toxicity towards host cells. These compounds show potent inhibition of the replication of the human immunodeficiency virus (HIV) while remaining largely inert toward human DNA.

Career Highlights

Throughout his career, McLaughlin has worked with reputable organizations, including Ensemble Therapeutics Corporation and The Trustees of Boston College. His work has significantly impacted the development of therapeutic agents aimed at combating viral infections.

Collaborations

Some of his notable coworkers include James M Coull and Lawrence A Haff, who have collaborated with him on various projects, contributing to the advancement of his research and inventions.

Conclusion

Larry W McLaughlin's innovative work in nucleic acid detection and anti-viral compounds highlights his commitment to addressing pressing health issues through scientific advancements. His contributions continue to influence the fields of biotechnology and medicine.